What stage does Cobro Ventures invest at?

Cobro Ventures invests at the Seed, Series A stages.

What sectors does Cobro Ventures focus on?

Cobro Ventures focuses on AI & Machine Learning, Biotech, Deep Tech, Enterprise Software, SaaS.

Where is Cobro Ventures located?

Cobro Ventures is headquartered in Mclean, US.

Cobro Ventures

Venture capital

Mclean · Seed–Series A · 3 people tracked

★ Follow + Add to CRM ⤳ Find an introduction

✨ Fox Verdict

Investment thesis

Cobro Ventures invests in technology and biotech businesses, drawing on a 25+ year track record as founders, operators, and investors with multiple exits through IPO and M&A. Launched by the entrepreneurs behind OPNET Technologies, the firm embraces a 'doing well by doing good' philosophy. It seeks high-impact opportunities, backs world-class scientific and technology experts, and leverages its experience with intellectual property and strategic business development to build significant value.

Invests inAI & Machine Learning Biotech Deep Tech Enterprise Software SaaSMcleanUnited States

Source: firm website, verified Aug 11, 2026.

Stage

Seed–Series A

Mclean, Virginia, US

Instruments

Equity

Founded

2013

Private fund assets

$76M

VC funds

Tracked investments

Team · 3 people

from public directories

Todd Kaloudis· General Partner· New York, New Yorkin

Todd Kaloudis is Managing Partner at Kalogent, where he operates a selective advisory practice serving B2B companies on sales acceleration and valuation. Over twenty years, he has held leadership roles in sales, business development, marketing, revenue operations, solution engineering, and finance across OPNET Technologies, Dynatrace, Platform Science, and GroundWork Renewables, with experience spanning IPO, M&A, and private financing outcomes. He holds a degree in computer science with a concentration in artificial intelligence from MIT.

t•••@cobroventures.comreveal

Arthur Becker· Venture Partner· New York, New Yorkin

Arthur Becker is Executive Chair of iPilldispenser and AffordX.ai. He currently serves as CEO of Oncopep, a cancer vaccine company developing proprietary peptides for Phase II trials in triple negative breast cancer, and as Chairman of VisgenX, which focuses on treatments for dry age-related macular degeneration. His prior roles include CEO of NaviSite, a NASDAQ-listed internet hosting company (2002-2010), and Chairman & CEO of Zinio, a digital newsstand platform (2012-2015), along with venture and investment positions at CoBro Ventures and Madison Technology LLC.

Marc Cohen· Investor· Virginiain

What they invest in

from 3 of 3 portfolio companies

Biotech ×3AI & Machine Learning ×1Deep Tech ×1

HQs:United States×3

Investments · 3 tracked

founders shown can be your intro path

By year:2023 · 1 2022 · 23 dated

AI Proteinsaiproteins.bioin 𝕏Jul 2023SEC filingmedium confidence

AI Proteins designs engineered miniproteins for drug discovery and development in the biopharmaceutical industry.

AI & Machine LearningBiotechDeep TechAndover, US

Dominique Verhelle(Director)Bill McKee(Director)Julia Novina(Executive Officer)Marc A. Cohen(Executive Officer, Director)Geoff Meyerson(Director)Elena Prokupets(Director)

Board seatTodd Kaloudis· per SEC Form D · $10M raise · filed Aug 2023

Microbial Machines, Inc.Apr 2022SEC filingmedium confidence

BiotechAndover, US

Drew Dennison(Chief Executive Officer)Bobby Sandage(Director)Carl Novina(Director)Jeffrey Wagner(Chief Scientific Officer)Tom Erickson(Director)Julia A. Novina(Chief Legal Officer)

Board seatTodd Kaloudis· per SEC Form D · $13.9M raise · filed May 2022

NextRNA TherapeuticsJan 2022SEC filingmedium confidence

BiotechCambridge, US

Carl Novina(Director)Elena Prokupets(Director)Barry Polisky(Director)Andrea Armstrong(Director)Dominique Verhelle(Director)Marc A. Cohen(Executive Officer, Director)

Board seatArthur Becker· per SEC Form D · $50M raise · filed Jan 2022

Rows marked “SEC filing” are inferred from directors named on the company's SEC Form D — public regulatory data, not a portfolio list published by the firm.

Portfolio news

latest coverage across their companies

AI Proteins Raises $41.5M Series A Financing to Advance De Novo Miniproteins as a New Therapeutic Modality - BioSpace

AI Proteins · biospace.com · Nov 20, 2025

Frequently asked questions

What stage does Cobro Ventures invest at?: Cobro Ventures invests at the Seed, Series A stages.
What sectors does Cobro Ventures focus on?: Cobro Ventures focuses on AI & Machine Learning, Biotech, Deep Tech, Enterprise Software, SaaS.
Where is Cobro Ventures located?: Cobro Ventures is headquartered in Mclean, US.

Similar investors

ACT Venture Capital

ACT Venture Capital is an independent Irish venture capital firm that invests €1 million to €15 million in growth-stage private companies, with capacity for larger commitments through syndicated rounds.

$1.1M – $16.2M

B Capital Group

B Capital Group is a global venture capital firm that backs founders from early to late stage, with dedicated stage-based funds and a portfolio spanning technology, healthcare, and energy and resilience sectors.

$10M – $50M

Bessemer Venture Partners

Bessemer Venture Partners is a venture capital firm that partners with entrepreneurs from early stages through every stage of growth, publishing investment roadmaps across multiple technology sectors.

$5M – $100M

DCVC (Data Collective)

DCVC (Data Collective) is a venture capital firm that backs founders building companies which apply technology to major challenges across areas such as energy, biotech, agriculture, and machine learning.

$5M – $25M

Hoxton Ventures

Hoxton Ventures is a European venture capital firm with a Silicon Valley mindset that invests early in founders building companies in new, non-obvious market categories, encouraging them to tackle the US market early.

$500K – $5M